Daily dose: 2,330mcg (2.33mg) total blend This breaks down to approximately: 1,700mcg (1.7mg) GHK-Cu 330mcg TB-500 330mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks, followed by 2-4 week rest period Schedule: Daily injection at consistent time For a standard 70mg glow peptide vial reconstituted with 3mL bacteriostatic water, this protocol requires 0.10mL (10 units on an insulin syringe) per daily injection
N., Fernandes, M
The theoretical basis is sound
For broader scientific reading on the compounds, researchers can explore peer-reviewed publications on PubMed BPC-157 and PubMed Thymosin Beta-4
Assesses the acid/base balance to ensure minimal irritation upon injection and confirm the solution is within the correct range for subcutaneous administration
With a clean Arginine Salt delivery method, third-party lab testing, and capsule-based convenience, it stands out among the best BPC-157 peptides for sale online today